S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Fair value lists · updated after every US close (16 Oct 2026)

Undervalued & overvalued stocks

Ranked by the gap to fair value — then sort by financial health, growth, debt, profitability or dividends to separate real bargains from value traps.

Most undervalued Most overvalued Undervalued + quality
Sort by Gap to fair value ↑ X-Ray Score Financial health Growth Lowest debt Profitability (ROIC) Dividend yield Piotroski F-Score
Then by
Only show Financial health ≥ 70 ✓ Low debt (< 1.5× EBITDA) Growth ≥ 50 Pays dividend ≥ 2% Piotroski ≥ 7

Most overvalued — US stocks

Sorted by Gap to fair value (low → high) · 8 shown of 58
$639.01$237.99
-63%
54
61
75
0.5×
81%
0.5%
8/9
OvervaluedHigh uncertainty · 40% margin
$1,210.86$443.28
-63%
55
80
77
Data missing
31%
0.6%
7/9
OvervaluedMedium uncertainty · 30% margin
$313.83$112.31
-64%
47
55
82
0.9×
33%
0.6%
6/9
OvervaluedHigh uncertainty · 40% margin
$170.51$53.53
-69%
41
36
40
0.1×
265%
—
6/9
OvervaluedMedium uncertainty · 30% margin
$313.59$98.30
-69%
52
53
49
0.8×
24%
1.2%
6/9
OvervaluedMedium uncertainty · 30% margin
$82.69$25.15
-70%
52
43
66
Data missing
–
0.4%
5/9
OvervaluedHigh uncertainty · 40% margin
$500.80$135.22
-73%
60
73
55
Data missing
–
1.3%
8/9
OvervaluedMedium uncertainty · 30% margin
$1,439.07$370.40
-74%
52
74
50
Net cash
30%
0.2%
7/9
OvervaluedHigh uncertainty · 40% margin
Click any column to sort · 58 stocks in this listPage 2 of 2
← PreviousPage 2 of 2
Financial health (0–100)
Piotroski F-Score, Altman Z, interest cover, liquidity: ranked within sector.
Growth (0–100)
Revenue, EPS and free-cash-flow growth over the last three years.
Net debt / EBITDA
Years of earnings needed to repay debt. "Net cash" means more cash than debt.
ROIC
Return on invested capital: how efficiently the business earns profit.
Dividend yield
Trailing 12-month dividends ÷ price.
Piotroski F-Score (0–9)
9 accounting tests of profitability, leverage and efficiency.

Model estimates, not price targets or recommendations. For educational purposes only. Not financial advice.